These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 16234565
1. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo. del Carmen MG, Rizvi I, Chang Y, Moor AC, Oliva E, Sherwood M, Pogue B, Hasan T. J Natl Cancer Inst; 2005 Oct 19; 97(20):1516-24. PubMed ID: 16234565 [Abstract] [Full Text] [Related]
2. C225 and PDT combination therapy for ovarian cancer: the play's the thing. Cengel KA, Hahn SM, Glatstein E. J Natl Cancer Inst; 2005 Oct 19; 97(20):1488-9. PubMed ID: 16234556 [No Abstract] [Full Text] [Related]
14. Augmentation of a humanized anti-HER2 mAb 4D5 induced growth inhibition by a human-mouse chimeric anti-EGF receptor mAb C225. Ye D, Mendelsohn J, Fan Z. Oncogene; 1999 Jan 21; 18(3):731-8. PubMed ID: 9989823 [Abstract] [Full Text] [Related]
15. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Ciardiello F, Caputo R, Bianco R, Damiano V, Pomatico G, De Placido S, Bianco AR, Tortora G. Clin Cancer Res; 2000 May 21; 6(5):2053-63. PubMed ID: 10815932 [Abstract] [Full Text] [Related]
16. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC. Krause M, Schütze C, Petersen C, Pimentel N, Hessel F, Harstrick A, Baumann M. Radiother Oncol; 2005 Feb 21; 74(2):109-15. PubMed ID: 15734198 [Abstract] [Full Text] [Related]
17. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery. Safavy A, Bonner JA, Waksal HW, Buchsbaum DJ, Gillespie GY, Khazaeli MB, Arani R, Chen DT, Carpenter M, Raisch KP. Bioconjug Chem; 2003 Feb 21; 14(2):302-10. PubMed ID: 12643740 [Abstract] [Full Text] [Related]
19. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J, Fan Z. Clin Cancer Res; 2000 Feb 21; 6(2):701-8. PubMed ID: 10690556 [Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer. Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J, Hong WK. Clin Cancer Res; 2001 May 21; 7(5):1204-13. PubMed ID: 11350885 [Abstract] [Full Text] [Related] Page: [Next] [New Search]